|
|||||||||
|
Product
Name
|
Key
Ingredients1
|
Price2
|
Shipping
Costs3 |
Efficacy4
|
Ease
of Acqui- sition4 |
Safety4
|
Ingre-
dient Mix4 |
Side
Effects4 |
Ease
of Use4
|
Value4
|
Overall
Score5
|
|
Epivir
|
lamivudine
|
$13.00
|
$250.00
|
75
|
40
|
60
|
70
|
60
|
80
|
60
|
445
|
NOTICE: For your convenience we copied key information from each product's site and have provided it here, with some content edited to make it more readable.
3TC, trade name Epivir (also known as lamivudine), is an anti-HIV treatment
in the same class of drugs as AZT, ddI, ddC and d4T. These drugs are called
nucleoside analogs. The body breaks down these drugs into chemicals that stop
HIV from infecting uninfected cells in the body, but they do not help cells
that have already been infected with the virus. As people with AIDS lose T4
cells - one of the immune systems main defenses - they become more likely to
get infections and illnesses.
Studies have shown that when taken alone 3TC has a strong anti-HIV effect at first, but the virus can quickly become resistant and the anti-HIV effects wear off. Many studies have now shown that using 3TC in combination with two other anti-HIV drugs can prevent the virus from getting resistant, and this has helped people live longer and get less opportunistic infections. 3TC is an important part of combination anti-HIV treatment. Ideally, 3TC should be used as part of a carefully chosen combination of anti-HIV treatments in order to get the most benefit.
New Public Health Service HIV treatment guidelines say that the best way to use 3TC is in combination with other anti-HIV drugs. The guidelines recommend combinations of three or four anti-HIV drugs as first treatment for HIV:
Two nucleoside analogs (AZT+3TC,
d4T+3TC, d4T+ddI, AZT+ddI, or AZT+ddC) with one of the following: Crixivan,
Fortovase, Norvir, Sustiva, Viracept or Norvir and Fortovase combined.
If one of the above combinations cannot be used, an alternative is two nucleoside
analogs (same combinations as listed above) with Viramune or Rescriptor.
Studies have also shown that 3TC can reduce the amount of hepatitis B virus
to very low levels, although this effect does not always last. 3TC is not yet
approved for the treatment of hepatitis B.
Dosage: The recommended dosage of 3TC is 150 mg twice a day. 3TC is also available in a syrup form for children. 3TC can be taken with or without food. There is also a pill that combines 3TC with another nucleoside analog drug made by the same manufacturer. This pill is called Combivir and combines 150mg of 3TC with 300mg of AZT.
Side effects: 3TC has few side-effects, mainly nausea, vomiting, headaches, and rare cases of hair loss. Although not as common as with some other anti-HIV drugs, 3TC can cause damage to the nerves in the hands and feet. This condition is called peripheral neuropathy. The symptoms of peripheral neuropathy are burning or numbing sensations in the hands and feet which can become very painful. If 3TC causes this problem, it may be necessary to switch to another anti-HIV drug to prevent permanent nerve damage.
In children, 3TC can cause a side effect called pancreatitis. Pancreatitis is a dangerous swelling of an organ in the body called the pancreas. Children taking 3TC should be carefully monitored for this side effect.
A rare but serious side effect of nucleoside analog anti-HIV drugs is called lactic acidosis. This side effect is caused by the drugs damaging liver cells. The symptoms are severe nausea and vomiting that does not get better. If you're taking anti-HIV drugs and experiencing these symptoms, make sure your provider has checked for lactic acidosis.
Warning: If you're going to use 3TC, it's important to check for infection with hepatitis B. If you have active hepatitis B when you start 3TC, you may feel sick for a month or two because liver cells infected with hepatitis B die off. Liver enzymes may also increase temporarily. These symptoms are a lot like some drug side effects, and knowing your hepatitis status can help tell the difference. There have also been several reports of hepatitis B flare-ups when 3TC treatment is stopped. Symptoms of hepatitis B flare-ups are high liver enzymes, yellow skin (jaundice), nausea and vomiting.
Glaxo-Wellcome has a patient
assistance program for people having problems getting the drug. The number to
call is (800) 722-9294. People that have been receiving the drug through the
expanded access program and who now need help with reimbursement should call
(800) 513-3028.
1 Based on
information obtained from manufacturer's/retailer's website.
2 Reflects approximately average retail price as provided by popular online
drugstores and other supplement outlets.
3 Reflects approximately average shipping costs as provided by popular online
drugstores and other supplement outlets.
4 Our opinion only, not based on statistical analysis of study results supplied
by manufacturer or other source.
5 Based on our opinion only, calculated by considering its price, shipping costs,
efficacy, ingredients/content, value or any combination of the categories.
|
ImmuneReport.com is not prescribing medications or diagnosing diseases or immune conditions. Always consult with your health care provider before applying any product, adding any substances to your diet, or making any lifestyle changes. The web site and its product reviews are our opinions only, and are not intended to diagnose, treat, cure, or prevent any disease. Please note: We urge EVERYONE who reads this site to get the advice of a physician before using ANY product. Always consult with your health care provider before applying any product, adding any substances to your diet, or making any lifestyle changes. Immune System disorders are caused by a variety of environmental, genetic, and age factors in addition to disease. Even when the symptoms disappear after treatment these factors may continue to exist. Symptoms may therefore reappear at a later date. Statements on some of the Non-Prescription products that are reviewed by ImmuneReport.com have not been evaluated by the Food and Drug Administration, therefore are NOT classified as a device to treat or cure any disease. Your use of this Web Site is entirely at your risk - the Web Site is provided "as is," and we disclaim any and all responsibility for the accuracy, timeliness, and completeness of the information contained on the Site. We shall not be responsible for any loss or damage suffered by you or anyone else in connection with this Web Site or the information contained in it.
|
|
Send mail to webmaster@immunereport.com with questions or comments about this web site. Copyright © 2002-2006 ImmuneReport.com, all rights reserved. All information tabulated on this page current as of August 28th, 2001. Last modified: November 15th, 2006. |